Revenue Recognition (Details) - USD ($) |
3 Months Ended | 9 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2023 |
Apr. 30, 2022 |
Apr. 30, 2023 |
Apr. 30, 2022 |
Feb. 01, 2023 |
Aug. 01, 2022 |
Jul. 31, 2022 |
Feb. 01, 2022 |
Aug. 01, 2021 |
|
| Revenue Recognition (Details) [Line Items] | |||||||||
| Accounts receivables | $ 9,636,000 | $ 9,636,000 | $ 10,866 | $ 11,516 | $ 11,516,000 | $ 15,316 | $ 10,198 | ||
| Clinical Services Revenue [Member] | |||||||||
| Revenue Recognition (Details) [Line Items] | |||||||||
| Percentage of clinical services business | 56.00% | 71.00% | 54.00% | 71.00% | |||||
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|